Evidence map›Paper›PMID 38451608›Full record

ArticleBrazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica2024

Association among cardiopulmonary and metabolic rehabilitation, arrhythmias, and myocardial ischemia responses of patients with HFpEF or HFmrEF.

C A C Hossri, F C Araujo, B G Baldi, R Otterstetter, V R Uemoto, C R R Carvalho, L E Mastrocola, A L P Albuquerque

Open access · goldAbstract read
In one paragraph

Article in Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

C A C HossriHospital do Coração, Associação Beneficente Síria, São Paulo, SP, Brasil.ORCID http://orcid.org/0000-0002-2023-1143
F C AraujoFCA Sports, Belo Horizonte, MG, Brasil.ORCID http://orcid.org/0000-0002-8384-0480
B G BaldiHospital do Coração, Associação Beneficente Síria, São Paulo, SP, Brasil.ORCID http://orcid.org/0000-0002-9609-5117
R OtterstetterSchool of Exercise and Nutrition Sciences, University of Akron, Akron, OH, USA.ORCID http://orcid.org/0000-0001-8509-7259
V R UemotoSetor da Bioengenharia, Instituto Dante Pazzanese, São Paulo, SP, Brasil.ORCID http://orcid.org/0000-0002-9629-4298
C R R CarvalhoHospital do Coração, Associação Beneficente Síria, São Paulo, SP, Brasil.ORCID http://orcid.org/0000-0002-1618-8509
L E MastrocolaHospital do Coração, Associação Beneficente Síria, São Paulo, SP, Brasil.ORCID http://orcid.org/0000-0002-4632-4540
A L P AlbuquerqueHospital do Coração, Associação Beneficente Síria, São Paulo, SP, Brasil.ORCID http://orcid.org/0000-0003-3486-5240
Instituto Dante Pazzanese de Cardiologia · BRUniversity of Akron · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There's limited evidence of the potential benefits of cardiopulmonary and metabolic rehabilitation (CPMR) in patients with heart failure with preserved ejection fraction (HFpEF) or mildly reduced ejection fraction (HFmrEF) and coronary artery disease (CAD). The aim of this study was to investigate the impact of CPMR on the myocardial ischemia response (MIR), exercise-induced arrhythmias (EIA), New York Heart Association (NYHA) functional class, heart rate recovery (HRR), Borg CR10 perceived symptoms, and the SF-36 physical and mental health summary scores. A prospective cohort study was conducted with 106 patients undergoing 12 weeks of CPMR who completed two exercise tests pre- and post-CPMR: 1) maximum incremental test (CPX) and 2) submaximal constant load test (SUB). After CPMR, the effects on MIR, EIA, NYHA functional class, and HRR during both tests were analyzed. There was a significant change in NYHA functional classes after CPMR, with 96% of the patients in class I (vs 62% pre-CPMR, P<0.0001), 4% in class II (vs 32%), and none in class III (vs 6%). There was a significant reduction in the frequency of EIA (P<0.05) and MIR (P<0.001) and a significantly improved performance on both CPX and SUB tests (P<0.0001). Lastly, there was significant progress in the recovery metrics like HRR (P<0.0001), the Borg CR10 (P<0.0001), and the SF-36 summary scores (P<0.0001). The CPMR resulted in a significant decrease in EIA, delayed ischemia threshold in CPX and SUB tests, increased functional capacity, and improved quality of life.

Indexed as

Coronary Artery DiseaseHeart FailureMyocardial IschemiaArrhythmias, CardiacHumansProspective StudiesQuality of LifeStroke Volume

Identifiers

PMID38451608
PMCPMC10913385
OpenAlexW4392404064

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.